/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.44%
Natural Gas
+0.33%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.18%
VIX
N/A
Economic Calendar
EUR/USD
+0.44%
Natural Gas
+0.33%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.18%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Composite PMI Drops To 50.9, Missing Analyst Expectations
about 3 hours ago
German Services PMI Rises to a 10-Month High 53.3 in April
about 10 hours ago
Gold Prices at a Crossroads: Indicators Signal Caution
1 day ago
The Week Ahead: US Inflation, Private Sector PMIs, and the Bank of Japan in Focus
3 days ago
Will Next Week’s Big Tech Earnings Reinvigorate the Market?
3 days ago
Five Things to Know in Crypto This Week: The Halving, the Fed, and the Middle East
4 days ago
Is The Dip In Commodities A Buying Opportunity?
39 minutes ago
EUR/USD, GBP/USD, USD/CAD, USD/JPY Forecasts – U.S. Dollar Pulls Back As Composite PMI Misses Expectations
about 1 hour ago
Nasdaq 100, Dow Jones, S&P 500 News: Wall Street Gains Momentum on Tech, Automotive Earnings Surge
about 2 hours ago
US Dollar (DXY) Index News: Greenback Tumbles Following Bearish PMI Data
about 3 hours ago
Gold Price Slides Even Without Dollar’s Help!
about 3 hours ago
Natural Gas Price Forecast – Natural Gas Continues to Consolidate
about 4 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
IOVA
profile
Iovance Biotherapeutics Inc
Follow
IOVA
(
Nasdaq - US
)
Closed
11.80
+0.48 (+4.24%)
in
:
usd
•
As of: Apr 23, 2024 13:20
UTC -4
Open
11.56
High
11.85
Low
11.43
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Iovance Biotherapeutics Inc
CEO
Frederick G. Vogt
Headquarters
825 industrial road, suite 400
san carlos, ca 94070, united states
Auditor
Ernst & Young LLP
Employees
557
Share Holders
17
Website
www.iovance.com
Industry
biotechnology
Sector
health technology
Company Overview
Iovance Biotherapeutics is a clinical-stage pharmaceutical company primarily focused on the development and commercialization of novel T cell-based cancer immunotherapies. These immunotherapies use Generation 2 ('Gen 2') tumor infiltrating lymphocyte (TIL), which harnesses the power of a patient's own immune system to eradicate cancer cells.
Iovance Biotherapeutics Inc
Statistics
Valuation Measures
Market Capitalization
2
3.30B
Enterprise Value
3.18B
Enterprise Value/EBITDA
(ttm)
-7.38
Price to Earnings Ratio
(ttm)
N/A
Price to Book
(mrq)
4.95
Price to Sales
(ttm)
N/A
Price to Cash
(ytd)
N/A
Profitability
Gross Margin
(ttm)
-598.08%
Operating Margin
(ttm)
N/A
Profit Margin
(ttm)
-23290.14%
Return on Equity
(ttm)
-70.93%
Return on Invested Capital
(ttm)
-71.18%
Return on Assets
(ttm)
-55.25%
Income Statement
Revenue
(ttm)
1.19M
Revenue Per Share
(ttm)
0.00
Gross Profit
(ttm)
-9.57M
EBITDA
(ttm)
3
-431.04M
Net Income Avi to Common
(ttm)
-444.04M
Diluted EPS
(ttm)
-1.88
Share Statistics
Beta (5Y Monthly)
0.62
52-Week Change
107.02%
S&P500 52-Week Change
22.54%
S&P500 Member
No
Stock Optionable
Yes
Total Shares Outstanding
1
279.31M
Dividend Yield
0.00%
Float
4
250.26M
%
Held by Insiders
10.40%
%
Held by Institutions
77.03%
Balance Sheet
Total Cash
(mrq)
279.87M
Total Cash Per Share
(mrq)
1.00
Total Debt
(mrq)
1000.00K
Total Debt/Equity
(mrq)
0.17%
Current Ratio
(mrq)
2.79%
Quick Ratio
(mrq)
2.70%
Book Value Per Share
(mrq)
2.28
Cash Flow
Operating Cash Flow Per Share
(ytd)
-1.54
Free Cash Flow
(ytd)
-384.11M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker